Skip to main content
. 2020 Apr 9;12(4):928. doi: 10.3390/cancers12040928

Figure 2.

Figure 2

Cytotoxic effect of trabectedin in primary cell cultures derived from ACC patients. Cells were treated with increasing concentrations of trabectedin (0.0625 nM–0.75 nM) for four days. Cell viability was analyzed by MTT assay. Results are expressed as percent of viable cells vs. untreated cells ± SD; ** p < 0.001; *** p < 0.0001. (A): ACC03 primary cell culture; (B): ACC06-I primary cell culture; (C): ACC24-I primary cell culture; (D): ACC29 primary cell culture; (E): ACC32 primary cell culture.